{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:57:10Z","timestamp":1781614630166,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To provide local data on the prevalence and risk factors of diabetic macular edema in the Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A cross-sectional cohort study was conducted to screen the prevalence of diabetic macular edema among diabetic patients, with 906 patients randomly selected between May 2023 and September 2023 in a tele-screening program using OCT and fundus photos at the Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a sample of 906 diabetic patients who participated in a tele-screening program, 38 cases of diabetic macular edema (DME) were diagnosed, resulting in a prevalence of 4.19%. Males and females each composed 50% of the sample. The average age was 61.39 years (SD\u2009=\u200910.114), and 31.6% had diabetes for over 15 years. Most patients had comorbidities, including hypertension (86.8%) and dyslipidemia (89.5%). Diabetic complications were common: neuropathy was present in 23.6%, and nephropathy was present in 21%. Among the 48 eyes assessed, the mean central macular thickness was 315\u2009\u00b1\u200969\u00a0\u03bcm. The distribution of diabetic retinopathy severity in 48 eyes included 17 (35%) no retinopathy, 8 (17%) mild NPDR, 15 (31%) moderate NPDR, 7 (15%) severe NPDR, and 1 (2%) PDR. Center-involved DME was found in 45.8% of the eyes, whereas non-center-involved DME was observed in 54.2% of the eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study in Riyadh, Saudi Arabia, revealed a 4.19% prevalence of diabetic macular edema (DME), emphasizing the importance of regular screening, especially for patients with longstanding diabetes, hypertension, and dyslipidemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00747-5","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:10:11Z","timestamp":1762524611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of diabetic macular edema among type II diabetic patients in tele-screening program using OCT and fundus photos in a tertiary hospital, Riyadh, Saudi Arabia"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4405-3219","authenticated-orcid":false,"given":"Abdullrahman Mohammed","family":"Alshehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8434-3148","authenticated-orcid":false,"given":"Mohammed Naji","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2506-9990","authenticated-orcid":false,"given":"Mishari","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-6952","authenticated-orcid":false,"given":"Abdullmajeed","family":"Alfakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"747_CR1","doi-asserted-by":"crossref","unstructured":"AlHarbi M, Othman A, Nahari AA, Al-Jedai AH, Cuadras D, Almalky F, et al. Burden of illness of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: a five-year longitudinal study. Adv Ther. 2024;1\u201331.","DOI":"10.1007\/s12325-023-02772-y"},{"issue":"2","key":"747_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.survophthal.2022.11.008","volume":"68","author":"OA -Sorour","year":"2023","unstructured":"Sorour OA, Levine ES, Baumal CR, Elnahry AG, Braun P, Girgis J, et al. Persistent diabetic macular edema: definition, incidence, biomarkers, and treatment methods. Surv Ophthalmol. 2023;68(2):147\u201374.","journal-title":"Surv Ophthalmol"},{"key":"747_CR3","doi-asserted-by":"publisher","first-page":"1128811","DOI":"10.3389\/fmed.2023.1128811","volume":"10","author":"CD -Haydinger","year":"2023","unstructured":"Haydinger CD, Ferreira LB, Williams KA, Smith JR. Mechanisms of macular edema. Front Med. 2023;10:1128811.","journal-title":"Front Med"},{"issue":"4","key":"747_CR4","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.survophthal.2022.01.009","volume":"67","author":"JH -Im","year":"2022","unstructured":"Im JH, Jin YP, Chow R, Yan P. Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: a systematic review and meta-analysis. Surv Ophthalmol. 2022;67(4):1244\u201351.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"747_CR5","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1111\/aos.12532","volume":"93","author":"K -Al-Rubeaan","year":"2015","unstructured":"Al-Rubeaan K, Abu El-Asrar AM, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, et al. Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National diabetes Registry-based study. Acta Ophthalmol. 2015;93(2):e140\u20137.","journal-title":"Acta Ophthalmol"},{"key":"747_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/OPTH.S27363","volume":"6","author":"MF -El-Bab","year":"2012","unstructured":"El-Bab MF, Shawky N, Al-Sisi A, Akhtar M. Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia. Clin Ophthalmol. 2012;6:269\u201376.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"747_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.15537\/smj.2015.4.10371","volume":"36","author":"S -Hajar","year":"2015","unstructured":"Hajar S, Al Hazmi A, Wasli M, Mousa A, Rabiu M. Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia. Saudi Med J. 2015;36(4):449\u201355.","journal-title":"Saudi Med J"},{"issue":"3","key":"747_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/0974-9233.65502","volume":"17","author":"AR -Khan","year":"2010","unstructured":"Khan AR, Wiseberg JA, Lateef ZAA, Khan SA. Prevalence and determinants of diabetic retinopathy in al Hasa region of Saudi arabia: primary health care center based cross-sectional survey, 2007\u20132009. Middle East Afr J Ophthalmol. 2010;17(3):257\u201362.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"2","key":"747_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15537\/smj.2021.2.25623","volume":"42","author":"AS -AlQahtani","year":"2021","unstructured":"AlQahtani AS, Hazzazi MA, Waheeb SA, Semidey VA, Elgendy HK, Alkhars WI, et al. Saudi Arabia guidelines for diabetic macular edema: a consensus of the Saudi retina group. Saudi Med J. 2021;42(2):131\u20138.","journal-title":"Saudi Med J"},{"issue":"10","key":"747_CR10","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY -Wong","year":"2018","unstructured":"Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the international Council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125(10):1608\u201322.","journal-title":"Ophthalmology"},{"issue":"2","key":"747_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jcjo.2018.07.004","volume":"54","author":"T -Felfeli","year":"2019","unstructured":"Felfeli T, Alon R, Merritt R, Brent MH. Toronto tele-retinal screening program for detection of diabetic retinopathy and macular edema. Can J Ophthalmol. 2019;54(2):203\u201311.","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"747_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0896-1549(02)00043-3","volume":"15","author":"C -Pelzek","year":"2002","unstructured":"Pelzek C, Lim JI. Diabetic macular edema: review and update. Ophthalmol Clin North Am. 2002;15(4):555\u201363.","journal-title":"Ophthalmol Clin North Am"},{"issue":"2","key":"747_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/0974-9233.151887","volume":"22","author":"DA -Salz","year":"2015","unstructured":"Salz DA, Witkin AJ. Imaging in diabetic retinopathy. Middle East Afr J Ophthalmol. 2015;22(2):145\u201350.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"747_CR14","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00125-010-1836-3","volume":"53","author":"E -Heintz","year":"2010","unstructured":"Heintz E, Wir\u00e9hn AB, Peebo BB, Rosenqvist U, Levin L\u00c5. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia. 2010;53:2147\u201354.","journal-title":"Diabetologia"},{"key":"747_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/DMSO.S447658","volume":"17","author":"AC -Garc\u00eda-Ulloa","year":"2024","unstructured":"Garc\u00eda-Ulloa AC, P\u00e9rez-Peralta L, Jaime-Casas S, Jim\u00e9nez-Corona A, Rivera-De La Parra D, Graue-Hern\u00e1ndez EO, et al. Risk factors associated with diabetic retinopathy with and without macular edema in recently diagnosed patients with type 2 diabetes. Diabetes Metab Syndr Obes. 2024;17:231\u20138.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"747_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2008.10.016","volume":"116","author":"R -Klein","year":"2009","unstructured":"Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin epidemiologic study of diabetic retinopathy XXIII: the 25-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116(3):497\u2013503.","journal-title":"Ophthalmology"},{"issue":"4","key":"747_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1056-8727(03)00038-2","volume":"18","author":"PR -Aroca","year":"2004","unstructured":"Aroca PR, Salvat M, Fern\u00e1ndez J, M\u00e9ndez I. Risk factors for diffuse and focal macular edema. J Diabetes Complications. 2004;18(4):211\u20135.","journal-title":"J Diabetes Complications"},{"issue":"5","key":"747_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archopht.1995.01100050069033","volume":"113","author":"BE -Klein","year":"1995","unstructured":"Klein BE, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol. 1995;113(5):601\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"747_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.pcd.2017.03.002","volume":"11","author":"E -Mart\u00edn-Merino","year":"2017","unstructured":"Mart\u00edn-Merino E, Fortuny J, Rivero-Ferrer E, Lind M, Garcia-Rodriguez LA. Risk factors for diabetic macular edema in type 2 diabetes: a case-control study in a united Kingdom primary care setting. Prim Care Diabetes. 2017;11(3):288\u201396.","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"747_CR20","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3390\/biomedicines11051502","volume":"11","author":"Y -Suzuki","year":"2023","unstructured":"Suzuki Y, Kiyosawa M. Relationship between diabetic nephropathy and development of diabetic macular edema in addition to diabetic retinopathy. Biomedicines. 2023;11(5):1502.","journal-title":"Biomedicines"},{"key":"747_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12886-018-0753-y","volume":"18","author":"D -Acan","year":"2018","unstructured":"Acan D, Calan M, Er D, Arkan T, Kocak N, Bayraktar F, et al. The prevalence and systemic risk factors for diabetic macular edema: a cross-sectional study from Turkey. BMC Ophthalmol. 2018;18:129.","journal-title":"BMC Ophthalmol"},{"key":"747_CR22","first-page":"49","volume-title":"Diabetic macular edema","author":"S -Saxena","year":"2023","unstructured":"Saxena S, Meyer CH, Gilhotra JS, Akduman L. Targeted screening of macular edema by spectral domain optical coherence tomography for progression of diabetic retinopathy: translational aspects. In: Saxena S, Meyer CH, Akduman L, editors. Diabetic macular edema. Singapore: Springer; 2023. pp. 49\u201353."},{"issue":"5","key":"747_CR23","first-page":"NC05","volume":"16","author":"C -Sareddy","year":"2022","unstructured":"Sareddy C, Nagpal S, Muzumdar D. Macular thickness \u2013 an early predictor of diabetic macular edema. J Clin Diagn Res. 2022;16(5):NC05\u20138.","journal-title":"J Clin Diagn Res"},{"key":"747_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1089043","volume":"2018","author":"L -Rangaraju","year":"2018","unstructured":"Rangaraju L, Jiang X, McAnany JJ, Tan MR, Wanek J, Blair NP, et al. Association between visual acuity and retinal layer metrics in diabetics with and without macular edema. J Ophthalmol. 2018;2018:1\u20137.","journal-title":"J Ophthalmol"},{"issue":"1","key":"747_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ijerph15010157","volume":"15","author":"RM -Kashim","year":"2018","unstructured":"Kashim RM, Newton P, Ojo O. Diabetic retinopathy screening: a systematic review on patients\u2019 nonattendance. Int J Environ Res Public Health. 2018;15(1):157.","journal-title":"Int J Environ Res Public Health"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00747-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:21:35Z","timestamp":1781612495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-025-00747-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00747-5","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by King Abdullah International Medical Research Center (KAIMRC), Protocol Number: NRC23R\/262\/03.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}